Skip to content Skip to footer

2001

Journal Article

The microsomal epoxide hydrolase Tyr113His polymorphism: Association with risk of ovarian cancer

Spurdle, Amanda B., Purdie, David M., Webb, Penelope M., Chen, Xiaoqing, Green, Adele and Chenevix-Trench, Georgia (2001). The microsomal epoxide hydrolase Tyr113His polymorphism: Association with risk of ovarian cancer. Molecular Carcinogenesis, 30 (1), 71-78. doi: 10.1002/1098-2744(200101)30:13.0.CO;2-9

The microsomal epoxide hydrolase Tyr113His polymorphism: Association with risk of ovarian cancer

2000

Journal Article

CYP17 promoter polymorphism and breast cancer in Australian women under age forty years

Spurdle, Amanda B., Hopper, John L., Dite, Gillian S, Chen, Xiaoqing, Cui, Jisheng, McCredie, Margaret R. E., Giles, Graham G., Southey, Melissa C., Venter, Deon J., Easton, Douglas F. and Chenevix-Trench, Georgia (2000). CYP17 promoter polymorphism and breast cancer in Australian women under age forty years. Journal of the National Cancer Institute, 92 (20), 1674-1681. doi: 10.1093/jnci/92.20.1674

CYP17 promoter polymorphism and breast cancer in Australian women under age forty years

2000

Journal Article

CYP17 promotor polymorphism and ovarian cancer risk

Spurdle, Amanda B., Chen, Xiaoqing, Abbazadegan, Mohammed, Martin, Nicholas, Khoo, Soo-Keat, Hurst, Terry, Ward, Bruce, Webb, Penelope M. and Chenevix-Trench, Georgia (2000). CYP17 promotor polymorphism and ovarian cancer risk. International Journal of Cancer, 89 (2), 436-439.

CYP17 promotor polymorphism and ovarian cancer risk

2000

Journal Article

CYP17 promotor polymorphism and ovarian cancer risk

Spurdle, Amanda B., Chen, Xiaoqing, Abbazadegan, Mohammed, Martin, Nicholas, Khoo, Soo-Keat, Hurst, Terry, Ward, Bruce, Webb, Penelope M. and Chenevix-Trench, Georgia (2000). CYP17 promotor polymorphism and ovarian cancer risk. International Journal of Cancer, 86 (3), 436-439. doi: 10.1002/(SICI)1097-0215(20000501)86:33.0.CO;2-A

CYP17 promotor polymorphism and ovarian cancer risk

2000

Journal Article

Androgen receptor EXON 1 CAG repeat length and risk of ovarian cancer

Spurdle, A. B., Webb, P. M., Chen, X. D., Martin, N. G., Giles, G. G., Hopper, J. L. and Chenevix-Trench, G. (2000). Androgen receptor EXON 1 CAG repeat length and risk of ovarian cancer. International Journal of Cancer, 87 (5), 637-643. doi: 10.1002/1097-0215(20000901)87:53.0.CO;2-R

Androgen receptor EXON 1 CAG repeat length and risk of ovarian cancer

1999

Journal Article

Androgen receptor exon 1 CAG repeat length and breast cancer in women before age forty years

Spurdle, A. B., Dite, G. S., Chen, X. Q., Mayne, C. J., Southey, M. C., Batten, L. E., Chy, H., Trute, L, McCredie, M. R. E., Giles, G. G., Armes, J., Venter, D. J., Hopper, J. L. and Chenevix-Trench, G. (1999). Androgen receptor exon 1 CAG repeat length and breast cancer in women before age forty years. Journal of the National Cancer Institute, 91 (11), 961-966. doi: 10.1093/jnci/91.11.961

Androgen receptor exon 1 CAG repeat length and breast cancer in women before age forty years

1999

Journal Article

Number of X-linked androgen receptor gene CAG repeats and femininity in women.

Loehlin, J. C., Spurdle, A. B., Treloar, S. A. and Martin, N. G. (1999). Number of X-linked androgen receptor gene CAG repeats and femininity in women.. Personality & Individual Differences, 27 (5), 887-899. doi: 10.1016/S0191-8869(99)00038-0

Number of X-linked androgen receptor gene CAG repeats and femininity in women.